Posted on 7/31/20
What's Behind Alexion Pharmaceuticals' Strong Q2 Results
Alexion Pharmaceuticals (NASDAQ:ALXN) stock has been on a big roll over the last few months. However, it hasn't been enough to outperform the S&P 500 index . . .
Posted on 7/30/20
Infinity Pharmaceuticals Provides Company Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its second quarter 2020 financial results and provided an update on the company, including its second quarter . . .
Posted on 7/30/20
Kebotix Expands With Second Research Lab
CAMBRIDGE, Mass. & WOBURN, Mass.--(BUSINESS WIRE)--Looking to grow by scaling operations and accelerating R&D efforts, Kebotix, a Cambridge-based technology platform company for new chemicals and materials, . . .
Posted on 7/30/20
Cyclerion Therapeutics Completes $24 Million Private Placement
CAMBRIDGE, Mass., July 30, 2020 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company developing treatments for serious and orphan diseases, today announced . . .
Posted on 7/30/20
Alexion Reports Second Quarter 2020 Results
BOSTON--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced financial results for the second quarter of 2020. Total revenues in the second quarter were $1,444.6 million, a 20 . . .
Posted on 7/30/20
resTORbio Provides Corporate Update and Reports Second Quarter 2020 Financial Results
BOSTON, July 30, 2020 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent . . .
Posted on 7/30/20
Evelo Biosciences Reports Second Quarter 2020 Financial Results and Business Highlights
CAMBRIDGE, Mass., July 30, 2020 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting . . .
Posted on 7/30/20
Agios Reports Business Highlights and Second Quarter 2020 Financial Results
CAMBRIDGE, Mass., July 30, 2020 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and rare . . .
Posted on 7/30/20
BioTelemetry Announces Sales Agent Agreement with Boston Scientific
MALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve . . .
Posted on 7/30/20
Should Moderna Be Your Next Coronavirus Stock?
Moderna (NASDAQ:MRNA) has already grabbed plenty of headlines in 2020 while racing through the development and testing process for its experimental COVID-19 vaccine, mRNA-1273. But its . . .
Posted on 7/30/20
Report: Moderna Sets Price Range for Coronavirus Vaccine
Considered by many observers to be the leader in the hunt for a coronavirus vaccine, Moderna (NASDAQ:MRNA) has apparently settled on a price for its potential . . .
Posted on 7/29/20
Mass General Brigham Hospitals Named Among Best Hospitals by U.S. News & World Report
Boston, MA, July 28, 2020 (GLOBE NEWSWIRE) -- Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH), the founding members of Mass General Brigham, earned . . .
Posted on 7/29/20
TCR² Therapeutics Prices Public Offering of Common Stock
CAMBRIDGE, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company with a pipeline of novel T cell therapies for . . .
Posted on 7/29/20
BioXcel Therapeutics Prices Public Offering of Common Stock
NEW HAVEN, Conn., July 28, 2020 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical development company, today announced the pricing of an underwritten public . . .
Posted on 7/29/20
Corbus Pharmaceuticals Strengthens Balance Sheet with up to $121M in New Capital
Norwood, MA, July 29, 2020 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid . . .
Posted on 7/29/20
4G Clinical Named to Fast Company's Second Annual List Of The 100 Best Workplaces for Innovators
Fast Company today announced its second annual Best Workplaces for Innovators list, honoring businesses and organizations that demonstrate a deep commitment to encouraging innovation at all . . .
Posted on 7/29/20
SEKISUI Diagnostics Invests £14.4 Million in cGMP Biopharma CDMO Capacity
Sekisui announces the decision to invest £14.4 Million in its biopharma CDMO business aimed at cGMP microbial capacity expansion at the existing site in Maidstone, Kent . . .
Posted on 7/29/20
Omega Therapeutics Completes $85M in Financing
Omega Therapeutics, a company pioneering a new category of genomic medicine through epigenomic programming, today announced the completion of an $85 million financing.
Posted on 7/29/20
Thrive Earlier Detection Raises $257M In Series B
Thrive Earlier Detection Corp., a company dedicated to extending and saving lives by incorporating earlier cancer detection into routine medical care, today announced that it has . . .
Posted on 7/29/20
Thermo Fisher: A Strong First Semester Doesn't Mean It's Cheap
SummaryThermo Fisher's share price has increased by more than 60% since the March lows.Despite a good free cash flow result in H1, the valuation is perhaps . . .
Posted on 7/29/20
Warren Buffett Invests Almost $400 Million More in Bank of America
The Oracle of Omaha is bullish on Bank of America (NYSE:BAC). That much is clear.Days after revealing that he had invested another $813 million in one . . .
Posted on 7/29/20
3 Reasons to Buy Moderna Stock, and 1 Reason to Sell It
The share price of clinical-stage biotech Moderna (NASDAQ:MRNA) has risen 245% since it announced on Feb. 10 that it had already designed and produced its first . . .
Posted on 7/28/20
Thermo Fisher Scientific and Lyell Immunopharma Form Cell Therapy Manufacturing Partnership
Thermo Fisher Scientific Inc., the world leader in serving science, and biotechnology company Lyell Immunopharma, are partnering to develop manufacturing processes designed to create more effective . . .
Posted on 7/28/20
Agenus Receives $35M In Immuno-Oncology Transaction with Betta Pharmaceuticals
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with an extensive pipeline of agents designed to activate immune response to cancers, today announced the closing of . . .
Posted on 7/28/20
NH-Based Rock Ledge Group Donates $425,000 of N95 Respirators to Boston Children’s Hospital
BOSTON--(BUSINESS WIRE)--On July 23rd, Rock Ledge Group donated 100,000 N95 Respirator Masks to Boston Children's Hospital. The donation will be used to protect the more than . . .
Boston
